HuGE Literature Finder
Records
1
-
5
Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML. Cancer immunology research 2018 Apr . Ureshino Hiroshi, Shindo Takero, Kojima Hiroto, Kusunoki Yasushi, Miyazaki Yuki, Tanaka Hidenori, Saji Hiroh, Kawaguchi Atsushi, Kimura Shin |
Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy. Cancer immunology research 2014 Dec 2 (12): 1142-7. Tanimine Naoki, Tanaka Yuka, Kobayashi Tsuyoshi, Tashiro Hirotaka, Miki Daiki, Imamura Michio, Aikata Hiroshi, Tanaka Junko, Chayama Kazuaki, Ohdan Hide |
Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. PloS one 2014 9 (1): e84940. De Re Valli, Caggiari Laura, De Zorzi Mariangela, Talamini Renato, Racanelli Vito, D' Andrea Mario, Buonadonna Angela, Zagonel Vittorina, Cecchin Erika, Innocenti Federico, Toffoli Giusep |
HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients. International journal of surgery (London, England) 2014 12 (8): 815-20. Kim Hyung-Jin, Choi Hae-Baeg, Jang Jung-Pil, Baek In-Cheol, Choi Eun-Jeong, Park Miyoung, Kim Tai-Gyu, Oh Seong-Ta |
Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Human immunology 2010 Oct 71 (10): 976-81. Al Omar Suliman, Middleton Derek, Marshall Ernie, Porter Dawn, Xinarianos George, Raji Olaide, Field John K, Christmas Stephen |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: